Key result
Prehypertension labeling lacks evidence for improving outcomes and risks psychological harm without clear benefit.
Answers are grounded in this paper and cite their sources.
Avoid prehypertension diagnosis in practice; leaves open need for trials on labeling effects.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Anthony J. Viera (2007) conducted a letter in Prehypertension. Diagnosing prehypertension was evaluated. Diagnosing prehypertension lacks evidence for improving patient-oriented outcomes and may cause negative psychological and social effects similar to hypertension labeling.
Synapse has enriched 10 related papers. Consider them for comparative context: